spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving its pharma, biotech and CRO readership expert insight and analysis on the sponsor-service provider landscape.

EPC focuses on key trends, concerns and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.

 

For further information please contact:

Advertising
Craig Hannington 

Editorial
Niamh O'Brien

We're also on Twitter! Follow us @EPCmagazine

The latest digital edition of EPC can be viewed here
 

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


epc
 
 
Featured in this issue
Supply Chain Management
Supply Management
 
Getting Interactive


Utilisation of intelligent IRT systems is the best way to meet the demands of clinical supply management, argues Stefan Dürr at Cenduit, as this can save time and eliminate unnecessary work.
DATA MANAGEMENT
Electronic Data Interchange

Destination: Automation


A hands-off approach to trials, through to the automation of processes such as the managing of inventories, is a new industry goal, but Ian Davison at HMD Clinical suggests that this raises its own questions.
  Supply Chain Management
Local Trial Supply

The Hungarian Way


Many countries in the CEE region are now looking to local companies for several supply activities, so Tibor Kovacs at PharmaRoad expands on the reasons why Hungary is leading this trend.

spacer



Published quarterly in
February, May,
August and November


 

Industry Events

DIA 2017 Annual Meeting

18-22 June 2017, Chicago, IL

Themed “Driving Insights to Action,” DIA 2017 will host 8,000+ professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries. DIA 2017 boasts more than 450 exhibiting companies, 10+ tracks, and 160+ sessions focused on regulatory science, translational medicine, patient engagement, and value and access. Follow DIA 2017 updates on Twitter using #DIA2017.
More info >>

 
News and Press Releases

Saneca to drive R&D Initiative following €1.5 million funding


More info >>

air transport logo

 

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement